Med Lasers.  2022 Jun;11(2):72-77. 10.25289/ML.2022.11.2.72.

A review on photobiomodulation therapy for olfactory dysfunction caused by COVID-19

• Ventura RD

• KMID: 2533574
• DOI: http://doi.org/10.25289/ML.2022.11.2.72

Abstract

Olfactory dysfunction is a loss of smell caused by a number of conditions such as chronic rhinosinusitis, neurodegenerative disease, aging, and viral infection, and it is a common symptom Coronavirus Disease 2019 (COVID-19). Photobiomodulation (PBM) is a non-invasive, safe, and effective treatment for a range of disorders. It has an anti-inflammatory action and stimulates tissue healing, which can help with the reversal of olfactory dysfunction. Due to the limited options for immunocom promised patients, there is currently a need for an alternative treatment method for olfactory dysfunction. This review highlights the most recent research on the use of PBM for the treatment of olfactory dysfunction.

Keyword

Photobiomodulation; Anosmia; Olfactory dysfunction; Low-level laser therapy